The University of Kansas Heartland Institute for Clinical and Translational Research (HICTR) was established in 2007 in response to the national CTSA initiative. The vision ofthe HICTR is to Improve the health of Kansans by creating a novel and transformative translational research enterprise from bench to bedside to community. Particular strengths of our HICTR program are an entrepreneurial drug and device discovery and development program and a well-developed and highly accomplished community-based research program.
The specific aims of the HICTR are to: 1) create a new academic home with innovative training programs for clinical and translational investigators;2) provide an enhanced coordinated translational research infrastructure;and 3) actively engage the community in developing, testing, and disseminating research, by capitalizing on and expanding existing networks, to improve the health of all Kansans?especially those in rural, underserved and other target communities. The proposed infrastructure and educational programs ofthe HICTR will address the challenges facing clinical and translational investigators by enhancing and integrating existing resources for easier access, developing new innovative resources, and capitalizing on resources residing in research centers across the university-including our KINBRE and five COBRE grants~and our HICTR network institutions. In support of our aims, we have marshaled an impressive array of institutional, corporate, and community resources in planning, developing, and establishing the HICTR. The HICTR will provide new infrastructure and training and educational programs to support investigators'clinical and translational research?taking laboratory discoveries to first trials in humans (Tl research) and moving research through to studies on dissemination and implementation of research findings to practice (T2 research). With extraordinary institutional and community support, we already have made tremendous progress. Funding from the CTSA program will allow the University of Kansas'HICTR the opportunity to fully realize its potential not only for our region, but also to contribute to the national CTSA Consortium.

Public Health Relevance

The University of Kansas Heartland Institute for Clinical and Translational Research is an academic home for clinical and translational research, providing support to scientists and involving the community, so that discoveries and research findings will be brought more rapidly to the point of care, thus improving the health of all Kansans.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Training Award (TL1)
Project #
8TL1TR000120-02
Application #
8270454
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Program Officer
Boller, Francois
Project Start
2011-06-01
Project End
2016-02-29
Budget Start
2012-03-01
Budget End
2013-02-28
Support Year
2
Fiscal Year
2012
Total Cost
$133,537
Indirect Cost
$8,714
Name
University of Kansas
Department
Neurology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Fletcher, Amanda N; Molteni, Agostino; Ponnapureddy, Rakesh et al. (2016) The renin inhibitor aliskiren protects rat lungs from the histopathological effects of fat embolism. J Trauma Acute Care Surg :
Britt, Nicholas S; Potter, Emily M (2016) Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections. J Glob Antimicrob Resist 5:57-61
Willig, Laurel K; Petrikin, Josh E; Smith, Laurie D et al. (2015) Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med 3:377-87
Yoo, Min; D'Silva, Linda J; Martin, Katherine et al. (2015) Pilot Study of Exercise Therapy on Painful Diabetic Peripheral Neuropathy. Pain Med 16:1482-9
Kluding, Patricia M; Pasnoor, Mamatha; Singh, Rupali et al. (2015) Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial. Phys Ther 95:223-34
Guimier, Anne; Gabriel, George C; Bajolle, Fanny et al. (2015) MMP21 is mutated in human heterotaxy and is required for normal left-right asymmetry in vertebrates. Nat Genet 47:1260-3
Britt, Nicholas S; Potter, Emily M; Patel, Nimish et al. (2015) Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clin Infect Dis 61:871-8
Heller, Aaron; McIff, Terence E; Lai, Sue-Min et al. (2015) Intrawound Vancomycin Powder Decreases Staphylococcal Surgical Site Infections After Posterior Instrumented Spinal Arthrodesis. J Spinal Disord Tech 28:E584-9
Pham, Vinh; Sykes, Kevin; Wei, Julie (2014) Long-term outcome of once daily nasal irrigation for the treatment of pediatric chronic rhinosinusitis. Laryngoscope 124:1000-7
Coyan, Garrett N; Reeder, K M; Vacek, James L et al. (2014) Diet and exercise interventions following coronary artery bypass graft surgery: a review and call to action. Phys Sportsmed 42:119-29

Showing the most recent 10 out of 15 publications